A
Andrew H. Karaba
Researcher at Johns Hopkins University School of Medicine
Publications - 49
Citations - 711
Andrew H. Karaba is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Medicine & Immunology. The author has an hindex of 10, co-authored 23 publications receiving 220 citations. Previous affiliations of Andrew H. Karaba include Northwestern University & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living with HIV.
Bezawit A. Woldemeskel,Andrew H. Karaba,Caroline C. Garliss,Evan J Beck,Kristy H Wang,Oliver Laeyendecker,Andrea L. Cox,Joel N. Blankson +7 more
TL;DR: In this article, the BNT162b2 vaccine induces robust immune responses comparable to responses in healthy donors in people living with HIV (PLWH), but responses to SARS-CoV-2 vaccines have not been fully characterized in these patients.
Journal ArticleDOI
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.
Jake A Ruddy,Brian J. Boyarsky,Justin R. Bailey,Andrew H. Karaba,Jacqueline Garonzik-Wang,Dorry L. Segev,Christine M. Durand,William A. Werbel +7 more
TL;DR: In this article, a study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV demonstrated uniformly high anti-SARS receptor binding domain antibody titers after two doses.
Journal ArticleDOI
Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports.
Journal ArticleDOI
Herpesvirus Entry Mediator and Nectin-1 Mediate Herpes Simplex Virus 1 Infection of the Murine Cornea
TL;DR: It is reported that either HVEM or nectin-1 must be present for HSV-1 infection of the cornea, and it is observed that the infection was attenuated in both HV EM KO and nectIn-1 KO mice, suggesting that receptor requirements for HSv vary depending on the route of inoculation and/or serotype.
Posted ContentDOI
A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients
Andrew H. Karaba,Xianming Zhu,Tao Liang,Kristy H Wang,Alex G Rittenhouse,Olivia Akinde,Yolanda Eby,Joel N. Blankson,Aura T. Teles,Jennifer L. Alejo,Andrea L. Cox,Andrea L. Cox,Justin R. Bailey,Sabra L. Klein,Sabra L. Klein,Andrew Pekosz,Andrew Pekosz,Jacqueline Garonzik-Wang,Brian J. Boyarsky,Dorry L. Segev,Aaron A.R. Tobian,William A. Werbel +21 more
TL;DR: For example, this article showed that a third SARS-CoV-2 vaccine dose increased median anti-spike (1.6-fold) and receptor-binding domain(1.5fold) IgG, as well as pseudoneutralization against VOCs (2.5-fold versus Delta).